Therefore, this study specifically focused on the TLR2/TLR4/NF-κB signaling pathway as the research target, investigating its temporal dynamics in mediating neuroinflammatory responses during the hyperacute phase of AIS. The gene discussed is NFKB1; the disease is androgen insensitivity syndrome.